Michelle J. Chandley

Michelle J. Chandley

Auto-generated profile, based on publicly available information

Michelle J. Chandley

Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA 37614

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2022 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Open access
MCMichelle J. Chandley
Michelle J. Chandley
ASAttila Szebeni
Attila Szebeni
KSKatalin Szebeni
Katalin Szebeni
HWHui Wang-Heaton
Hui Wang-Heaton
JGJacob Garst
Jacob Garst
GOGregory A. Ordway
Gregory A. Ordway
Major depressive disorder (MDD) and suicide have been associated with elevated indices of oxidative damage in the brain, as well as white matter pathology including reduced myelination by oligodendrocytes. Oligodendrocytes highly populate white matter and are inherently susceptible to oxidative damage. Pathology of white matter oligodendrocytes has been reported to occur in brain regions that process behaviors that are disrupted in MDD and that may contribute to suicidal behavior. The present study was designed to determine whether oligodendrocyte pathology related to oxidative damage extends to brain areas outside of those that are traditionally considered to contribute to the psychopathology of MDD and suicide. Relative telomere lengths and the gene expression of five antioxidant-related genes, SOD1, SOD2, GPX1, CAT, and AGPS were measured in oligodendrocytes laser captured from two non-limbic brain areas: occipital cortical white matter and the brainstem locus coeruleus. Postmortem brain tissues were obtained from brain donors that died by suicide and had an active MDD at the time of death, and from psychiatrically normal control donors. Relative telomere lengths were significantly reduced in oligodendrocytes of both brain regions in MDD donors as compared to control donors. Three antioxidant-related genes (SOD1, SOD2, GPX1) were significantly reduced and one was significantly elevated (AGPS) in oligodendrocytes from both brain regions in MDD as compared to control donors. These findings suggest that oligodendrocyte pathology in MDD and suicide is widespread in the brain and not restricted to brain areas commonly associated with depression psychopathology.

1 April 2009 in Schizophrenia Research
Verified
Journal Article
Closed access
MCMichelle J. Chandley
Michelle J. Chandley
MMMerry N. Miller
Merry N. Miller
CKChristine Newell Kwasigroch
Christine Newell Kwasigroch
TWTracy D. Wilson
Tracy D. Wilson
BMBarney E. Miller
Barney E. Miller

4 March 2020 in Autism Research
Verified
Journal Article
Open access
PDF file
ASAubrey N. Sciara
Aubrey N. Sciara
BBBrooke Beasley
Brooke Beasley
JCJessica D. Crawford
Jessica D. Crawford
EAEmma P. Anderson
Emma P. Anderson
TCTiffani Carrasco
Tiffani Carrasco
MCMichelle J. Chandley
Michelle J. Chandley
Evidence for putative pathophysiological mechanisms of autism spectrum disorder (ASD), including peripheral inflammation, blood–brain barrier disruption, white matter alterations, and abnormal synaptic overgrowth, indicate a possible involvement of neuroinflammation in the disorder. Neuroinflammation plays a role in the development and maintenance of the dendritic spines involved in glutamatergic and GABAergic neurotransmission, and also influences blood–brain permeability. Cytokines released from microglia can impact the length, location or organization of dendritic spines on excitatory and inhibitory cells as well as recruit and impact glial cell function around the neurons. In this study, gene expression levels of anti‐ and pro‐inflammatory signaling molecules, as well as oligodendrocyte and astrocyte marker proteins, were measured in both gray and white matter tissue in the anterior cingulate cortex from ASD and age‐matched typically developing (TD) control brain donors, ranging from ages 4 to 37 years. Expression levels of the pro‐inflammatory gene, HLA‐DR, were significantly reduced in gray matter and expression levels of the anti‐inflammatory gene MRC1 were significantly elevated in white matter from ASD donors as compared to TD donors, but neither retained statistical significance after correction for multiple comparisons. Modest trends toward differences in expression levels were also observed for the pro‐inflammatory (CD68, IL1β) and anti‐inflammatory genes (IGF1, IGF1R) comparing ASD donors to TD donors. The direction of gene expression changes comparing ASD to TD donors did not reveal consistent findings implicating an elevated pro‐ or anti‐inflammatory state in ASD. However, altered expression of pro‐ and anti‐inflammatory gene expression indicates some involvement of neuroinflammation in ASD. Autism Res 2020, 13: 870‐884. © 2020 The Authors. Autism Research published by International Society for Autism Research and Wiley Periodicals LLCLay Summary: The anterior cingulate cortex is an integral brain region in modulating social behaviors including nonverbal communication. The study found that inflammatory gene expression levels were altered in this brain region. We hypothesize that the inflammatory changes in this area could impact neuronal function. The finding has future implications in using these molecular markers to identify potential environmental exposures and distinct cell differences in autism.

16 May 2015 in Molecular Autism
Verified
Journal Article
Open access
PDF file
MCMichelle J Chandley
Michelle J Chandley
JCJessica D Crawford
Jessica D Crawford
ASAttila Szebeni
Attila Szebeni
KSKatalin Szebeni
Katalin Szebeni
GOGregory A Ordway
Gregory A Ordway
The anterior cingulate cortex (ACC) is a brain area involved in modulating behavior associated with social interaction, disruption of which is a core feature of autism spectrum disorder (ASD). Functional brain imaging studies demonstrate abnormalities of the ACC in ASD as compared to typically developing control patients. However, little is known regarding the cellular basis of these functional deficits in ASD. Pyramidal neurons in the ACC are excitatory glutamatergic neurons and key cellular mediators of the neural output of the ACC. This study was designed to investigate the potential role of ACC pyramidal neurons in ASD brain pathology. Postmortem ACC tissue from carefully matched ASD and typically developing control donors was obtained from two national brain collections. Pyramidal neurons and surrounding astrocytes were separately collected from layer III of the ACC by laser capture microdissection. Isolated RNA was subjected to reverse transcription and endpoint PCR to determine gene expression levels for 16 synaptic genes relevant to glutamatergic neurotransmission. Cells were also collected from the prefrontal cortex (Brodmann area 10) to examine those genes demonstrating differences in expression in the ACC comparing typically developing and ASD donors. The level of NTRK2 expression was robustly and significantly lower in pyramidal neurons from ASD donors as compared to typically developing donors. Levels of expression of GRIN1, GRM8, SLC1A1, and GRIP1 were modestly lower in pyramidal neurons from ASD donors, but statistical significance for these latter genes did not survive correction for multiple comparisons. No significant expression differences of any genes were found in astrocytes laser captured from the same neocortical area. In addition, expression levels of NTRK2 and other synaptic genes were normal in pyramidal neurons laser captured from the prefrontal cortex. These studies demonstrate a unique pathology of neocortical pyramidal neurons of the ACC in ASD. NTRK2 encodes the tropomyosin receptor kinase B (TrkB), transmission through which neurotrophic factors modify differentiation, plasticity, and synaptic transmission. Reduced pyramidal neuron NTRK2 expression in the ACC could thereby contribute to abnormal neuronal activity and disrupt social behavior mediated by this brain region.

1 September 2013
Verified
Report
Closed access
PDF file
GOGregory A. Ordway
Gregory A. Ordway
MCMichelle J. Chandley
Michelle J. Chandley
The overall goal of this proposed work is to begin elucidating the cellular and molecular basis of white matter abnormalities in autism spectrum disorder (ASD). Using laser capture microdissection (LCM), subpopulations of white matter glia, i.e. astrocytes and oligodendrocytes, can be isolated independently of other brain cells and analyzed for gene expression differences that might contribute to ASD pathology. The combination of LCM and transcriptional analysis offer an innovative approach to determining the cellular basis of brain pathology in ASD. Due to the time intensive nature of LCM, the first year of the grant was set aside primarily for sample collection. During this year, multiple LCM instrument failures have slowed the progress of cell capture. Despite setbacks, we were able to conduct preliminary feasibility studies and precisely determine the course of action to complete the project in the second year of the award. Our university has purchased a new Arcturus XT LCM instrument that is expected to arrive and be functional within the first two weeks of October this year. This annual report summarizes the efforts made to overcome unforeseen obstacles that have modestly impeded the progress of this grant.

1 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
LWLiza Judith Wills
Liza Judith Wills
HWHui Wang-Heaton
Hui Wang-Heaton
APAaron J. Polichnowski
Aaron J. Polichnowski
KTKristy Thomas
Kristy Thomas
BJBenjamin E. Jewett
Benjamin E. Jewett
MCMichelle J. Chandley
Michelle J. Chandley
Background: Major depressive disorder (MDD) affects approximately 20% of the population, with over 30% of cases demonstrating treatment resistance. Postmortem analyses have revealed increased poly (ADP-ribose) polymerase 1 (PARP-1) expression in prefrontal cortical white matter of individuals with MDD, suggesting PARP-1 as a potential therapeutic target. Chronic stress, a major risk factor for depression, affects multiple physiological domains including behavior, cardiovascular function, neuroinflammation, and gut-brain axis signaling. Methods: We conducted a comprehensive multi-system investigation of PARP inhibition effects on stress-induced pathophysiology using the social defeat stress/chronic unpredictable stress (SDS+CUS) rodent model. In the primary study, male Sprague-Dawley rats (N=32) underwent 10 days of SDS+CUS while receiving daily treatment with the PARP inhibitor 3-aminobenzamide (3-AB; 40mg/kg), selective serotonin reuptake inhibitor fluoxetine (FLX; 10mg/kg), or saline (0.9% NaCl), with non-stressed controls included. Behavioral outcomes were assessed via sucrose preference and social interaction tests. Neurobiological analyses examined PARP-1 expression, microglial morphology, and proinflammatory cytokine levels (IL-1β, TNF-α, IL-6) in relevant brain regions. In a parallel cardiovascular study, a separate cohort of stressed rats (N=8) received either saline or 3-AB treatment while hemodynamic parameters were monitored via telemetry before, during, and after stress exposure. Exploratory gut microbiome analyses were also conducted (see Supplemental Materials). Results: Saline-treated stressed rats demonstrated significantly elevated anhedonia and social avoidance compared to all other groups, while 3-AB treatment prevented these behavioral deficits. Cardiovascular monitoring revealed that stressed saline-treated rats developed significant elevations in systolic and mean blood pressure with decreased heart rate compared to baseline, whereas 3-AB treatment prevented these hemodynamic changes. Neurobiological analyses showed that FLX-treated stressed rats unexpectedly exhibited elevated PARP-1 expression in prefrontal cortical gray matter. Microglial morphological analysis revealed significantly more prolate (activated) microglia in the saline-treated stressed rats compared to all other treatment groups. Saline-treated stressed rats exhibited significantly increased hippocampal proinflammatory cytokines, with 3-AB treatment specifically normalizing TNF-α levels. Conclusion: PARP inhibition with 3-AB provides multi-system protection against chronic stress effects, preventing behavioral deficits, cardiovascular dysfunction, and neuroinflammation. These findings establish PARP-1 as a key mediator in the systemic pathophysiology of chronic stress and highlight PARP inhibition as a promising therapeutic approach for stress-related disorders with treatment-resistant features. Significant Outcomes: PARP inhibition with 3-aminobenzamide (3-AB) prevented stress-induced behavioral deficits (anhedonia and social avoidance) in a validated rodent model combining social defeat and chronic unpredictable stress. 3-AB treatment prevented stress-induced increases in arterial blood pressure. PARP inhibition prevented microglial activation and reduced proinflammatory cytokine expression (IL-1β and TNF-α) in stress-sensitive brain regions, supporting an anti-neuroinflammatory mechanism of action. FLX-treated stressed rats unexpectedly showed elevated PARP-1 expression in prefrontal cortical gray matter, suggesting a previously unrecognized interaction between serotonergic antidepressants and PARP-1 signaling that warrants further investigation. The multi-system protective effects of PARP inhibition, spanning behavioral, cardiovascular, and neuroinflammatory domains, suggest therapeutic potential for treatment-resistant depression. Limitations: This study examined only male rats, limiting generalizability to female subjects despite the higher prevalence of MDD in women. Behavioral assessments were limited to anhedonia and social interaction; additional tests of other depression-relevant behaviors would provide a more comprehensive phenotypic profile. Long-term effects of 3-AB treatment beyond the 10-day stress paradigm remain unexplored.